Surgery Partners Statistics
Total Valuation
SGRY has a market cap or net worth of $1.85 billion. The enterprise value is $5.38 billion.
Important Dates
The last earnings date was Tuesday, May 5, 2026, before market open.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SGRY has 129.59 million shares outstanding. The number of shares has increased by 1.09% in one year.
| Current Share Class | 129.59M |
| Shares Outstanding | 129.59M |
| Shares Change (YoY) | +1.09% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | 1.93% |
| Owned by Institutions (%) | 66.93% |
| Float | 56.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 30.34 |
| PS Ratio | 0.55 |
| Forward PS | 0.53 |
| PB Ratio | 1.08 |
| P/TBV Ratio | 1.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 2.22 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.61 |
| EV / EBITDA | 8.19 |
| EV / EBIT | 11.36 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.86, with a Debt / Equity ratio of 1.07.
| Current Ratio | 1.86 |
| Quick Ratio | 0.31 |
| Debt / Equity | 1.07 |
| Debt / EBITDA | 5.65 |
| Debt / FCF | n/a |
| Interest Coverage | 1.70 |
Financial Efficiency
Return on equity (ROE) is 2.75% and return on invested capital (ROIC) is 5.64%.
| Return on Equity (ROE) | 2.75% |
| Return on Assets (ROA) | 3.71% |
| Return on Invested Capital (ROIC) | 5.64% |
| Return on Capital Employed (ROCE) | 6.35% |
| Weighted Average Cost of Capital (WACC) | 9.33% |
| Revenue Per Employee | $208,975 |
| Profits Per Employee | -$4,756 |
| Employee Count | 16,000 |
| Asset Turnover | 0.42 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SGRY has paid $16.80 million in taxes.
| Income Tax | 16.80M |
| Effective Tax Rate | 14.75% |
Stock Price Statistics
The stock price has decreased by -39.11% in the last 52 weeks. The beta is 1.99, so SGRY's price volatility has been higher than the market average.
| Beta (5Y) | 1.99 |
| 52-Week Price Change | -39.11% |
| 50-Day Moving Average | 13.36 |
| 200-Day Moving Average | 17.54 |
| Relative Strength Index (RSI) | 59.40 |
| Average Volume (20 Days) | 1,104,440 |
Short Selling Information
The latest short interest is 15.84 million, so 12.22% of the outstanding shares have been sold short.
| Short Interest | 15.84M |
| Short Previous Month | 14.00M |
| Short % of Shares Out | 12.22% |
| Short % of Float | 27.83% |
| Short Ratio (days to cover) | 13.39 |
Income Statement
In the last 12 months, SGRY had revenue of $3.34 billion and -$76.10 million in losses. Loss per share was -$0.60.
| Revenue | 3.34B |
| Gross Profit | 763.30M |
| Operating Income | 474.00M |
| Pretax Income | 113.90M |
| Net Income | -76.10M |
| EBITDA | 657.70M |
| EBIT | 474.00M |
| Loss Per Share | -$0.60 |
Full Income StatementBalance Sheet
The company has $182.30 million in cash and $3.71 billion in debt, with a net cash position of -$3.53 billion or -$27.25 per share.
| Cash & Cash Equivalents | 182.30M |
| Total Debt | 3.71B |
| Net Cash | -3.53B |
| Net Cash Per Share | -$27.25 |
| Equity (Book Value) | 3.48B |
| Book Value Per Share | 13.15 |
| Working Capital | 500.80M |
Full Balance SheetCash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 183.70M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 22.83%, with operating and profit margins of 14.18% and -2.28%.
| Gross Margin | 22.83% |
| Operating Margin | 14.18% |
| Pretax Margin | 3.41% |
| Profit Margin | -2.28% |
| EBITDA Margin | 19.67% |
| EBIT Margin | 14.18% |
| FCF Margin | n/a |
Dividends & Yields
SGRY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.09% |
| Shareholder Yield | -1.09% |
| Earnings Yield | -4.11% |
| FCF Yield | n/a |
Analyst Forecast
The average price target for SGRY is $22.25, which is 55.59% higher than the current price. The consensus rating is "Buy".
| Price Target | $22.25 |
| Price Target Difference | 55.59% |
| Analyst Consensus | Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | 8.66% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |
